Swiss drugmaker Roche has found itself sitting on a gold mine with its Tamiflu antiviral drug in hot demand around the world because experts are pinning their hopes on it as the best defense against an influenza pandemic.
But the attention has put pressure on the company to step up production, cut prices and allow other companies to make copies of Tamiflu. Critics have questioned the company's intentions. Governments and individuals, fearing that the current bird flu virus could mutate into a strain that easily transmits among humans, have been snapping up supplies.
Roche, whose control of Tamiflu has been the subject of debate for weeks, opened its headquarters in Basel to reporters on Wednesday for a full-day tour and demonstration of the drug's manufacture -- which the company maintains is extremely complicated.
Top executives first briefed a packed amphitheater of reporters and then sent them on a three-hour tour of its plants, past swirling beakers, giant fermentation vats and filters.
The executives reiterated several times their philosophy that "the patient comes first" and sought to reassure governments concerned about bird flu, saying the company was producing enough of its antiviral drug Tamiflu to treat 55 million people this year.
David Reddy, the company's influenza pandemic task force leader, said production will be nearly tripled next year to 150 million treatments, and that in 2007, Roche will be in a position to make 300 million treatments.
In the same breath, executives played down the current threat of a pandemic and Tamiflu's role in the case it happened.
"At the moment it's an animal welfare and economic problem," said William Burns, chief executive of the pharmaceutical division, in an apparent reference of the slaughter of more than 150 million chickens and other poultry at farms primarily in Asia. "We need to keep a sense of balance and a sense of proportion."
"Pandemic preparedness is Tamiflu and more. The preparedness of society will need to be much greater. How are we going to keep the wheels of society turning? There won't be enough intensive care units or respiratory equipment," he said.
But John Oxford, a professor of virology at Queen Mary's University of London, who said he would receive a fee for speaking at the Roche briefing, insisted much of the burden rested with Tamiflu.
"We need plans and ammunition and Tamiflu is at least half of our ammunition," Oxford said, adding there was a clear relationship between the current H5N1 strain and the deadly Spanish flu virus of 1918-1919. "Without Tamiflu, we would be going into this naked."
He also warned that bird flu was "like the Scarlet Pimpernel: You never know where it's going to appear. And it's got a greater spectrum of variety than any other flu virus we've ever seen before."
Until last month, Roche had insisted it would not allow anyone else to make Tamiflu as sales of the once-obscure drug's sales have skyrocketed from US$76 million in 2001 to an expected US$1.1 billion to US$1.2 billion this year.
Consequently, Roche been accused of benefiting from a global health crisis, and has come under international pressure to ease its control on the manufacture of the drug.
The company was compared negatively to Bayer AG, the maker of anthrax treatment Cipro. In late 2001, as governments scrambled to stockpile Cipro in the face of US anthrax attacks, Bayer initially refused to disclose its production capacity or enter into reimbursement negotiations.
Burns argued that the increased pressure was partly due to "people wanting it yesterday because they only thought of it yesterday."
But the international aid agency Medecins Sans Frontieres (MSF) -- Doctors Without Borders -- disagrees.
"This simply shows the impracticality of one company trying to meet worldwide demand," said Daniel Berman of MSF's Access to Essential Medicines campaign. "This whole problem could be easily solved, though, if governments issued compulsory licenses. What everyone forgets is that if governments did that, Roche would not be left out."
Under WTO rules, countries can issue compulsory licenses to disregard patent rights but only after negotiating with the patent owners and paying them adequate compensation. If they declare a public health emergency, governments can skip the negotiating.
Berman, who called Roche executives "control freaks," noted that the company would still get standard 3 to 5 percent royalties on the product if governments issued compulsory licenses. However in such a case, Roche would not be allowed to control the sale price of the product, resulting in proportionally smaller royalties.
Conversely, a Merrill Lynch research report noted that "price discounts may be necessary in order to avoid compulsory licensing of its intellectual property by governments as the panic surrounding avian flu increases."
Burns said Roche will do everything necessary to ensure governments around the world can have access to the drug for pandemic stockpiles without violating the company's patent.
"We continue to look for ways to expand and speed up our output," Burns said.
But, he conceded, "There is a shortage right now."
Tropical Storm Gaemi strengthened into a typhoon at 2pm yesterday, and could make landfall in Yilan County tomorrow, the Central Weather Administration (CWA) said yesterday. The agency was scheduled to issue a sea warning at 11:30pm yesterday, and could issue a land warning later today. Gaemi was moving north-northwest at 4kph, carrying maximum sustained winds near its center of up to 118.8kph and gusts of 154.8kph. The circumference is forecast to reach eastern Taiwan tomorrow morning, with the center making landfall in Yilan County later that night before departing from the north coast, CWA weather forecaster Kuan Shin-ping (官欣平) said yesterday. Uncertainty remains and
SEA WARNING LIKELY: The storm, named Gaemi, could become a moderate typhoon on Wednesday or Thursday, with the Taipei City Government preparing for flooding A tropical depression east of the Philippines developed into a tropical storm named Gaemi at 2pm yesterday, and was moving toward eastern Taiwan, the Central Weather Administration (CWA) said. Gaemi could begin to affect Taiwan proper on Tuesday, lasting until Friday, and could develop into a moderate typhoon on Wednesday or Thursday, it said. A sea warning for Gaemi could be issued as early as Tuesday morning, it added. Gaemi, the third tropical storm in the Pacific Ocean this typhoon season, is projected to begin moving northwest today, and be closest to Taiwan on Wednesday or Thursday, the agency said. Today, there would likely
DISRUPTIONS: The high-speed rail is to operate as normal, while several airlines either canceled flights or announced early departures or late arrivals Schools and offices in 15 cities and counties are to be closed today due to Typhoon Gaemi, local governments announced last night. The 15 are: Taipei, New Taipei City, Taoyuan, Tainan, Keelung, Hsinchu and Kaohsiung, as well as Yilan, Hualien, Hsinchu, Miaoli, Chiayi, Pingtung, Penghu and Lienchiang counties. People should brace for torrential rainfall brought by the storm, with its center forecast to make landfall on the east coast between tonight and tomorrow morning, the Central Weather Administration (CWA) said. The agency issued a sea warning for the typhoon at 11:30pm on Monday, followed by a land warning at 11:30am yesterday. As of
CASUALTY: A 70-year-old woman was killed by a falling tree in Kaohsiung as the premier warned all government agencies to remain on high alert for the next 24 hours Schools and offices nationwide are to be closed for a second day today as Typhoon Gaemi crosses over the nation, bringing torrential rain and whipping winds. Gaemi was forecast to make landfall late last night. From Tuesday night, its outer band brought substantial rainfall and strong winds to the nation. As of 6:15pm last night, the typhoon’s center was 20km southeast of Hualien County, Central Weather Administration (CWA) data showed. It was moving at 19kph and had a radius of 250km. As of 3pm yesterday, one woman had died, while 58 people were injured, the Central Emergency Operation Center said. The 70-year-old